Mammalian & Microbial Biologics Manufacturing / Analytical Testing – CDMO
Following the build-out of its clinical-scale biomanufacturing facility, Scorpius needed to begin filling its manufacturing pipeline. Scorpius had spent the prior year saturating the market with exposure during its brand launch and now needed to begin fostering in-person engagements at two of the industry’s largest shows: CPHI and BIO International.
